Now, The Washington Post reports that a GLP-1 microdosing trend is sweeping the internet, and more than a dozen telehealth companies and medical practices have promoted taking small doses of the drugs for longevity
We extracted data on the following variables: study characteristics (author, year, country, study design, sample size, demographic characteristics of study participants, inclusion and exclusion criteria), intervention types, outcome measures, and duration of treatment (weeks)
A patient with obesity taking retatrutide for 68 weeks doesn't just lose 71 poundsthey reduce their 10-year risk of heart attack and stroke by an estimated 35-40% based on improved risk factors alone
At Metabolic Research Center, we understand that sustainable weight loss goes beyond merely counting calories